Volume 26, Number 8—August 2020
Synopsis
Epidemiology of Legionnaires’ Disease, Hong Kong, China, 2005−2015
Table 1
Factor | Total, no. (%), n = 288 | Severe, no. (%), n = 124 | Mild, no. (%), n = 164 | Crude odds ratio (95% CI) | Adjusted odds ratio (95% CI) |
---|---|---|---|---|---|
Male sex | 248 (86) | 108 (87) | 140 (85) | 1.16 (0.59–2.29) | 1.43 (0.61–3.36) |
Age >64 y | 140 (49) | 67 (54) | 73 (45) | 1.47 (0.92–2.34) | 1.17 (0.66–2.05) |
Smoker/former smoker |
173 (61)* |
79 (65) |
94 (58) |
1.38 (0.85–2.25) |
1.55 (0.86–2.78) |
History of chronic medical illnesses | |||||
Chronic renal failure/impairment | 46 (16) | 30 (24) | 16 (10) | 2.95 (1.53–5.71) | 4.09 (1.81–9.27) |
Chronic pulmonary diseases | 22 (8) | 15 (12) | 7 (4) | 3.09 (1.22–7.82) | 3.22 (1.10–9.42) |
Malignancy | 25 (9) | 15 (12) | 10 (6) | 2.12 (0.92–4.89) | 3.04 (1.17–7.91) |
Heart diseases | 69 (24) | 40 (32) | 29 (18) | 2.22 (1.28–3.84) | 2.15 (1.12–4.13) |
Hyperlipidemia | 53 (18) | 13 (11) | 40 (24) | 0.36 (0.19–0.71) | 0.17 (0.08–0.40) |
Diabetes | 109 (38) | 49 (40) | 60 (37) | 1.13 (0.70–1.83) | 0.94 (0.52–1.69) |
Hypertension | 161 (56) | 77 (62) | 84 (51) | 1.56 (0.97–2.51) | 1.62 (0.88–2.96) |
Immunosuppression | 22 (8) | 10 (8) | 12 (7) | 1.11 (0.46–2.66) | 0.75 (0.28–2.00) |
*Information for 4 patients was unknown.
Page created: March 31, 2020
Page updated: July 17, 2020
Page reviewed: July 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.